Reduction of intrathecal immunoglobulin levels with ocrelizumab treatment in relapsing and primary progressive multiple sclerosis

被引：0

作者：

Weber, Martin ^{[1
]}

Gelfand, Jeffrey ^{[2
]}

Bar-Or, Amit ^{[3
]}

Cameron, Briana ^{[4
]}

Ramesh, Akshaya ^{[4
]}

Anania, Veronica ^{[4
]}

von Budingen, H. -Christian ^{[5
]}

Herman, Ann ^{[4
]}

Spiciarich, David ^{[4
]}

Grondey, Katja ^{[1
]}

Schuetz, Konstantin ^{[1
]}

Winger, Ryan ^{[4
]}

Jia, Xiaoming ^{[4
]}

Harp, Christopher ^{[4
]}

Cross, Anne ^{[6
]}

机构：

[1] Univ Hosp Gottingen, Gottingen, Germany

[2] Univ Calif San Francisco, San Francisco, CA USA

[3] Univ Penn, Perelman Sch Med, Philadelphia, PA USA

[4] Genentech Inc, South San Francisco, CA USA

[5] F Hoffmann La Roche Ltd, Basel, Switzerland

[6] Washington Univ Sch Med, St Louis, MO USA

来源：

MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P653/1074

引用

页码：570 / 571

页数：2

共 50 条

[21] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis
Hauser, Stephen L.
Kappos, Ludwig
Montalban, Xavier
Hughes, Richard
McNamara, John
Pradhan, Ashish
Wormser, David
Koendgen, Harold
Wolinsky, Jerry S.
NEUROLOGY, 2019, 92 (15)
[22] Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis
Hauser, S. L.
Kappos, L.
Montalban, X.
Hughes, R.
Koendgen, H.
McNamara, J.
Pradhan, A.
Wormser, D.
Wolinsky, J. S.
MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 697 - 698
[23] Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis
Hauser, S. L.
Kappos, L.
Montalban, X.
Chognot, C.
Jessop, N.
Pradhan, A.
Prajapati, K.
Wolinsky, J. S.
MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 607 - 608
[24] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients with Relapsing and Primary Progressive Multiple Sclerosis
Kappos, Ludwig
Hauser, Stephen
Montalban, Xavier
Buffels, Regine
Chin, Peter
Li, Carrie
Mortensen, Deborah
Napieralski, Julie
Van Beek, Johan
Wormser, David
Wolinsky, Jerry
NEUROLOGY, 2017, 88
[25] Safety of ocrelizumab in multiple sclerosis: Updated analysis in patients with relapsing and primary progressive multiple sclerosis
Hauser, S.
Kappos, L.
Montalban, X.
Craveiro, L.
Hughes, R.
McNamara, J.
Pradhan, A.
Wormser, D.
Koendgen, H.
Wolinsky, J. S.
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
[26] Cost-effectiveness Analysis of Ocrelizumab for the Treatment of Relapsing and Primary Progressive Multiple Sclerosis in Portugal
Martins, Paulo
Vandewalle, Bjorn
Felix, Jorge
Capela, Carlos M.
Cerqueira, Joao J.
Salgado, Antonio, V
Ferreira, Diana G.
Monteiro, Isabel
PHARMACOECONOMICS-OPEN, 2023, 7 (02) : 229 - 241
[27] Cost-effectiveness Analysis of Ocrelizumab for the Treatment of Relapsing and Primary Progressive Multiple Sclerosis in Portugal
Paulo Martins
Björn Vandewalle
Jorge Félix
Carlos M. Capela
João J. Cerqueira
António V. Salgado
Diana G. Ferreira
Isabel Monteiro
PharmacoEconomics - Open, 2023, 7 : 229 - 241
[28] Effect of Ocrelizumab on Thalamic Atrophy in Patients with Relapsing and Primary Progressive Multiple Sclerosis
Arnold, Douglas L.
Sprenger, Till
Bar-Or, Amit
Wolinsky, Jerry S.
Kappos, Ludwig
Kolind, Shannon
Manfrini, Marianna
Magon, Stefano
van Beek, Johan
Koendgen, Harold
Bernasconi, Corrado
Gaetano, Laura
Traboulsee, Anthony
NEUROLOGY, 2020, 94 (15)
[29] Ocrelizumab for primary progressive multiple sclerosis
Adler, Ai
Knight, H.
LANCET NEUROLOGY, 2019, 18 (09): : 816 - 817
[30] Ocrelizumab for primary progressive multiple sclerosis
Montalban X
Hauser SL
Kappos L
中华物理医学与康复杂志, 2017, (03) : 174 - 174

← 1 2 3 4 5 →